Shared genetic etiology underlying Alzheimer's disease and type 2 diabetes

Molecular Aspects of Medicine

Volumn 43-44, Issue , 2015, Pages 66-76

  Hao, Ke ^a   Di Narzo, Antonio Fabio ^a   Ho, Lap ^a   Luo, Wei ^a,b   Li, Shuyu ^a   Chen, Rong ^a   Li, Tongbin ^c   Dubner, Lauren ^a   Pasinetti, Giulio Maria ^a,d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b HUAQIAO UNIVERSITY   (China)

^c AccuraScience LLC   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; eQTLs; GWAS; Pathway; Shared genomic component; Type 2 diabetes

Indexed keywords

ALLELE; ALZHEIMER DISEASE; CELL COMMUNICATION; GENE EXPRESSION; GENE FUNCTION; GENE ONTOLOGY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; HUMAN; IMMUNE RESPONSE; NERVE CELL PLASTICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; QUANTITATIVE TRAIT LOCUS; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; DIABETES MELLITUS, TYPE 2; GENETICS; GENOME-WIDE ASSOCIATION STUDY; PATHOLOGY;

ALZHEIMER DISEASE; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84943451142     PISSN: 00982997     EISSN: 18729452     Source Type: Journal    
DOI: 10.1016/j.mam.2015.06.006     Document Type: Review

References (48)

1. I.A. Adzhubei, S. Schmidt, L. Peshkin, V.E. Ramensky, A. Gerasimova, P. Bork, and et al. A method and server for predicting damaging missense mutations Nat. Methods 7 2010 248 249
2. Alzheimer's Association What is Alzheimer's? http://www.alz.org/alzheimers-disease-what-is-alzheimers.asp 2015
3. Alzheimer's Disease International Dementia statistics http://www.alz.co.uk/research/statistics 2013
4. M. Balietti, F. Tamagnini, P. Fattoretti, C. Burattini, T. Casoli, D. Platano, and et al. Impairments of synaptic plasticity in aged animals and in animal models of Alzheimer's disease Rejuvenation Res 15 2012 235 238
5. M. Bordonaro Role of Wnt signaling in the development of type 2 diabetes Vitam. Horm 80 2009 563 581
6. A.P. Boyle, Hong E.L., M. Hariharan, Cheng Y., M.A. Schaub, M. Kasowski, and et al. Annotation of functional variation in personal genomes using RegulomeDB Genome Res 22 2012 1790 1797
7. V. Chouraki, and S. Seshadri Genetics of Alzheimer's disease Adv. Genet 87 2014 245 294
8. Coronary Artery Disease (C4D) Genetics Consortium A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease Nat. Genet 43 2011 339 344
9. S. Craft, L.D. Baker, T.J. Montine, S. Minoshima, G.S. Watson, A. Claxton, and et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial Arch. Neurol 69 2012 29 38
10. N.G. Cruz, L.P. Sousa, M.O. Sousa, N.T. Pietrani, A.P. Fernandes, and K.B. Gomes The linkage between inflammation and type 2 diabetes mellitus Diabetes Res. Clin. Pract 99 2013 85 92
11. F.G. De Felice, and S.T. Ferreira Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease Diabetes 63 2014 2262 2272
12. J.L. Evans, I.D. Goldfine, B.A. Maddux, and G.M. Grodsky Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes Endocr. Rev 23 2002 599 622
13. D. Gautrin, and S. Gauthier Alzheimer's disease: environmental factors and etiologic hypotheses Can. J. Neurol. Sci 16 1989 375 387
14. D.M. Greenawalt, R. Dobrin, E. Chudin, I.J. Hatoum, C. Suver, J. Beaulaurier, and et al. A survey of the genetics of stomach, liver, and adipose gene expression from a morbidly obese cohort Genome Res 21 2011 1008 1016
15. E.J. Henriksen, M.K. Amond-Stanic, and E.M. Marchionne Oxidative stress and the etiology of insulin resistance and type 2 diabetes Free Radic. Biol. Med 51 2011 993 999
16. B. Howie, C. Fuchsberger, M. Stephens, J. Marchini, and G.R. Abecasis Fast and accurate genotype imputation in genome-wide association studies through pre-phasing Nat. Genet 44 2012 955 959
17. Huang D.W., B.T. Sherman, and R.A. Lempicki Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources Nat. Protoc 4 2009 44 57
18. Jiang T., Yu J.T., Tian Y., and Tan L. Epidemiology and etiology of Alzheimer's disease: from genetic to non-genetic factors Curr. Alzheimer Res 10 2013 852 867
19. K.S. Kendler A joint history of the nature of genetic variation and the nature of schizophrenia Mol. Psychiatry 20 2015 77 83
20. E.K. Kim, and E.J. Choi Pathological roles of MAPK signaling pathways in human diseases Biochim. Biophys. Acta 1802 2010 396 405
21. J.C. Lambert, C.A. Ibrahim-Verbaas, D. Harold, A.C. Naj, R. Sims, C. Bellenguez, and et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease Nat. Genet 45 2013 1452 1458
22. L.J. Launer, M.E. Miller, J.D. Williamson, R.M. Lazar, H.C. Gerstein, A.M. Murray, and et al. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy Lancet Neurol 10 2011 969 977
23. Y.J. Lee, Han S.B., S.Y. Nam, K.W. Oh, and Hong J.T. Inflammation and Alzheimer's disease Arch. Pharm. Res 33 2010 1539 1556
24. A.E. Locke, B. Kahali, S.I. Berndt, A.E. Justice, T.H. Pers, F.R. Day, and et al. Genetic studies of body mass index yield new insights for obesity biology Nature 518 2015 197 206
25. J.A. Luchsinger, and D.R. Gustafson Adiposity, type 2 diabetes, and Alzheimer's disease J. Alzheimers Dis 16 2009 693 704
26. T.A. Manolio, and F.S. Collins Genes, environment, health, and disease: facing up to complexity Hum. Hered 63 2007 63 66
27. B.W. Miller, K.C. Willett, and A.R. Desilets Rosiglitazone and pioglitazone for the treatment of Alzheimer's disease Ann. Pharmacother 45 2011 1416 1424
28. A.P. Morris, B.F. Voight, T.M. Teslovich, T. Ferreira, A.V. Segre, V. Steinthorsdottir, and et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes Nat. Genet 44 2012 981 990
29. J.K. Morris, R.A. Honea, E.D. Vidoni, R.H. Swerdlow, and J.M. Burns Is Alzheimer's disease a systemic disease? Biochim. Biophys. Acta 1842 2014 1340 1349
30. M. Muller, Tang M.X., N. Schupf, J.J. Manly, R. Mayeux, and J.A. Luchsinger Metabolic syndrome and dementia risk in a multiethnic elderly cohort Dement. Geriatr. Cogn. Disord 24 2007 185 192
31. P.C. Ng, and S. Henikoff SIFT: predicting amino acid changes that affect protein function Nucleic Acids Res 31 2003 3812 3814
32. P. Onso-Magdalena, I. Quesada, and A. Nadal Endocrine disruptors in the etiology of type 2 diabetes mellitus Nat. Rev. Endocrinol 7 2011 346 353
33. A.A. Podtelezhnikov, K.Q. Tanis, M. Nebozhyn, W.J. Ray, D.J. Stone, and A.P. Loboda Molecular insights into the pathogenesis of Alzheimer's disease and its relationship to normal aging PLoS ONE 6 2011 e29610
34. R.B. Prasad, and L. Groop Genetics of type 2 diabetes-pitfalls and possibilities Genes (Basel) 6 2015 87 123
35. G.A. Raciti, M. Longo, L. Parrillo, M. Ciccarelli, P. Mirra, P. Ungaro, and et al. Understanding type 2 diabetes: from genetics to epigenetics Acta Diabetol 2015 Epub ahead of print
36. J.A. Rios, P. Cisternas, M. Arrese, S. Barja, and N.C. Inestrosa Is Alzheimer's disease related to metabolic syndrome? A Wnt signaling conundrum Prog. Neurobiol 121 2014 125 146
37. E.J. Rossin, K. Lage, S. Raychaudhuri, R.J. Xavier, D. Tatar, Y. Benita, and et al. Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology PLoS Genet 7 2011 e1001273
38. H. Schunkert, I.R. Konig, S. Kathiresan, M.P. Reilly, T.L. Assimes, H. Holm, and et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease Nat. Genet 43 2011 333 338
39. B.E. Stranger, E.A. Stahl, and T. Raj Progress and promise of genome-wide association studies for human complex trait genetics Genetics 187 2011 367 383
40. R.E. Tanzi The genetics of Alzheimer disease Cold Spring Harb. Perspect. Med 2 2012 a006296
41. N.T. Vagelatos, and G.D. Eslick Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship Epidemiol. Rev 35 2013 152 160
42. Wang F., Guo X., Shen X., R.M. Kream, K.J. Mantione, and G.B. Stefano Vascular dysfunction associated with type 2 diabetes and Alzheimer's disease: a potential etiological linkage Med. Sci. Monit. Basic Res 20 2014 118 129
43. Wang J., Tang C., M.G. Ferruzzi, Gong B., Song B.J., E.M. Janle, and et al. Role of standardized grape polyphenol preparation as a novel treatment to improve synaptic plasticity through attenuation of features of metabolic syndrome in a mouse model Mol. Nutr. Food Res 57 2013 2091 2102
44. Wang K., Li M., and H. Hakonarson ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data Nucleic Acids Res 38 2010 e164
45. G.S. Watson, and S. Craft The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment CNS Drugs 17 2003 27 45
46. World Health Organization Diabetes fact sheet 2015
47. Zhang B., C. Gaiteri, L.G. Bodea, Wang Z., J. McElwee, A.A. Podtelezhnikov, and et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease Cell 153 2013 707 720
48. Zhang B., C. Gaiteri, L.G. Bodea, Wang Z., J. McElwee, A.A. Podtelezhnikov, and et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease Cell 153 2013 707 720